Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-014944

Chief Executive Officer sold 7,800 shares at an average $36.14 ($281,891)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-02-27 Sale −200 $35.22 $7,044 343,137 I
Ciechanover Isaac E. Chief Executive Officer 2019-02-27 Sale −3,700 $36.20 $133,940 339,437 I
Ciechanover Isaac E. Chief Executive Officer 2019-02-28 Sale −3,900 $36.13 $140,907 335,537 I
Open-market sales · 7,800 sh · avg $36.14 · $281,891
Loading xslF345X03/doc4.xml…